Latest collections open to submissions
NEW! Spatial tumor heterogeneity
Guest edited by Xiao Fu, Weini Huang, Robert Noble, Dmitrii Shek
NEW! Early-onset breast cancer
Guest edited by Matteo Lambertini, Kelly Metcalfe, Chiara Molinelli
Genomic instability in cancer
Guest edited by Albert Steven Agustinus and Viviana Barra
Editors' Picks
Trending BMC Cancer Articles
Click here to view which Articles have been shared most in the last month!
Articles
-
-
Prognostic value of interim PET/CT in GCB and non-GCB DLBCL: comparison of the Deauville five-point scale and the ΔSUVmax method
-
Detecting epithelial-mesenchymal transition signaling molecules in cervical epithelial cells aids in the early diagnosis of cervical lesions
-
Survival prediction of glioblastoma patients using machine learning and deep learning: a systematic review
-
A distinct subgroup of AML resembling the APL immunophenotype is associated with DIC
-
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
-
An electronic application for rapidly calculating Charlson comorbidity score
-
Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority
-
Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression
-
Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
_targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions
Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions
Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020
Cross journal collection: Precision Oncology
Collection published: 28 August 2019
Browse all BMC Cancer collection contributions
MULISARC trial: molecular profiling of advanced soft-tissue sarcomas
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy
Learn more about study protocols at BMC Cancer here
Aims and Scope
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here.
Become an Editorial Board Member
We are recruiting new Editorial Board Members.
Read MoreLatest Tweets
Your browser needs to have JavaScript enabled to view this timeline
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.4
5-year Journal Impact Factor: 3.8
Source Normalized Impact per Paper (SNIP): 0.944
SCImago Journal Rank (SJR): 1.087
Speed 2023
Submission to first editorial decision (median days): 12
Submission to acceptance (median days): 150
Usage 2023
Downloads: 7,974,312
Altmetric mentions: 3,975
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication